Vertex Pharma scientist talks about the long road to developing non
Time:2024-05-21 14:10:54 Source:healthViews(143)
WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Previous:Investigators return to Long Island home of Gilgo Beach serial killing suspect
Next:Analysis: Larson enters conversation with Verstappen as best drivers in the world
You may also like
- Minnesota Uber and Lyft driver pay package beats deadline to win approval in Legislature
- VOX POPULI: ‘Domicide’ is yet another terrible addition to the lexicon of war
- VOX POPULI: Voters won’t forget ‘politics of oblivion’ in the next election
- VOX POPULI: Young texters have rendered punctuation marks obsolete
- Yu Darvish extends scoreless innings streak to 25 in Padres' 9
- VOX POPULI: LDP lawmakers’ remarks about political funds create a paradox
- Princess of Wales: Data watchdog 'assessing' Kate privacy breach claims
- Luke Littler's Premier League darts rival Michael van Gerwen, 34, says the 17
- With Djokovic awaiting the winner, Murray trails Hanfmann at rain